Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

Not Applicable

• Conditions: Pain; Postoperative Pain
• Interventions: Drug: Bupivacaine 0.25% Injectable Solution

• Registration Number: NCT05117307
• Lead Sponsor: Erzurum Regional Training & Research Hospital

Brief Summary

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-04
• Study First Submitted QC: 2021-11-04
• Study First Posted: 2021-11-11
• Status Verified: 2021-12
• Study Start: 2021-12-01
• Last Update Submitted: 2021-12-09
• Last Update Posted: 2021-12-30
• Primary Completion: 2022-06-15
• Study Completion: 2022-06-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Between 18-50 years
• Cesarean Section

Exclusion Criteria

• Cesarean Section under general anesthesia
• emergency cases
• those with a body mass index greater than 35 kg/m2
• coagulopathy
• local infection

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group ESP	Bupivacaine 0.25% Injectable Solution	Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side
Group TFP	Bupivacaine 0.25% Injectable Solution	Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side

Primary Outcome Measures

Name	Time	Method
Opioid Consumption	Postoperative first 24 hours	Opioid consumption postroperative period

Secondary Outcome Measures

Name	Time	Method
Visual Analog Pain Score	Postoperative first 24 hours	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Trial Locations

Locations (1)

Erzurum Regional Training and Research Hospital; 🇹🇷 Erzurum, Yakutiye, Turkey